TRS II, LLC

Vitamin D3 Patch for Individuals Who Cannot Absorb Vitamin D

  • Stage Full Product Ready
  • Industry Consumer Products
  • Location Minneapolis, MN, USA
  • Currency USD
  • Founded September 2017
  • Employees 2
  • Incorporation Type LLC

Company Summary

TRS II has developed a Vitamin D transdermal patch that provides an investment opportunity which is supported by a strong, unmet, critical medical need, a multi-billion-dollar market potential and a ready-to-manufacture and sell, innovative, proprietary product. This is a “re-start” of a business that has already made product and sold product in a market where there is no alternative for patients who are Vitamin D mal-absorbers.

Team

  • Jim Stice
    COO

    Jim Stice, COO, has 30 years of early stage medical device product development and manufacturing experience as founder and management. Jim was most recently Co-founder & CEO of Twin Star Medical, a medical device company developing technology for site specific drug delivery. He has experience managing the development of medical device and combination products from concept through regulatory approval and then manufacturing.

  • Ted Schwarzrock
    CEO

    Ted Schwarzrock, CEO, has helped start and grow 5 early stage companies, including $55MM in revenue in the first year following FDA listing at SpineTech; grew Ergodyne sales from $10MM to over $42MM in 3 years; doubled BioMedical Dynamics sales in 1 year; grew Aequitron from startup to over $25MM in sales.Ted was most recently involved in transdermal drug delivery companies as founder and management, where he raised over $20 million in funding.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free